PHASE Scientific International has completed a Series A funding round, raising $34m for progressing the PHASIFY diagnostic.

Researchers at the University of Bath in the UK have developed a wearable belt-like device that can continuously scan the ...

Biosense Webster was deemed to have violated antitrust laws by withholding clinical support to hospitals using Innovative’s ...

Scientists from Kaunas University of Technology (KTU), Lithuania, have developed a system for integrated post-stroke ...

British healthtech company Huma Therapeutics has partnered with Eckuity Capital to lay the foundations for an ‘aggressive’ ...

The FDA has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD ...

Intravascular lithotripsy is quickly gaining the attention of the medtech industry’s giants. Yet distinguishing its true clinical promise from the financial buzz is no easy task.

The US Food and Drug Administration (FDA) has granted approval for Roche's VENTANA MET (SP44) RxDx Assay for NSQ-NSCLC.

Implantable lens developer STAAR will fund the repurchase using cash on hand and money generated from business operations.

The FDA has granted approval to Teal Health’s at-home vaginal sample self-collection device, Teal Wand, for cervical cancer ...

A new report by Royal Philips warns that the ‘trust gap’ around deploying artificial intelligence (AI) in healthcare systems ...

GE HealthCare has gained 501(k) clearance from the US Food and Drug Administration (FDA) for its CleaRecon DL technology.